ERJ Open Research (Oct 2020)

Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space

Sarah Orfanos,
Ibrahim El Husseini,
Thomas Nahass,
Jared Radbel,
Sabiha Hussain

Affiliations

Sarah Orfanos: Dept of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
Ibrahim El Husseini: Dept of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
Thomas Nahass: Dept of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
Jared Radbel: Dept of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
Sabiha Hussain: Dept of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA

DOI: https://doi.org/10.1183/23120541.00455-2020
Journal volume & issue: Vol. 6, no. 4

Abstract

No abstracts available.

Published in ERJ Open Research

ISSN: 2312-0541 (Online)
Publisher: European Respiratory Society
Country of publisher: United Kingdom
LCC subjects: Medicine
Website: https://openres.ersjournals.com/

About the journal